Endoscopic trans(naso)orbital management of supraorbital mucoceles with biliary T‐tube stenting

Man, Li-Xing; McLean, Caitlin; Pierce, Matthew L.; Fakhri, Samer

doi:10.1002/lary.23581

Cited by 6 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 To avoid this, stenting can be used to help to maintain patency in the postoperative period and can be left in for Ͼ1 year. 3 There is one previous small series by Man et al 13 that describes the use of biliary T tubes in marsupialization of frontal sinus mucoceles, but the use therein was for a much rarer type of pathology than was described here. Our study assessed the use of the biliary T tube in the far more common Draf III procedure, which showed that the biliary T-tube stent described here has a wider applicability than previously investigated.…”

Section: Discussionmentioning

confidence: 82%

Development of a Novel T-tube Frontal Sinus Irrigation Catheter

Rotenberg

Ioanidis

Sowerby

2016

Am J Rhinol�Allergy

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 82%

Development of a Novel T-tube Frontal Sinus Irrigation Catheter

Rotenberg

Ioanidis

Sowerby

2016

Am J Rhinol�Allergy

View full text Add to dashboard Cite

show abstract

“…For this, postoperative care is essential performing corticosteroid washes and debridements. Some propose using a stent made with a pediatric biliary T-tube, placed by frontal trephination and by an endonasal approach with endoscopes so that the drainage persists open [12].…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Surgery of Supraorbital Cells Mucoceles

Santiago¹,

Valentina²,

Carolina³

2021

J Otolaryngol Rhinol

View full text Add to dashboard Cite

Introduction: Mucoceles originating from supraorbital ethmoid cells are difficult to treat. Due to its lateral location the endonasal approach with endoscopes is sometimes not sufficient to achieve adequate exposure and the use of extended transnasal techniques and even external approaches is required.Objectives: To determine the success rate of surgical treatment performed endonasally with endoscopes or combined, endonasal and trough a transpalpebral approach to treat mucoceles originating in supraorbital cells.Methods: Patients with mucoceles originating in supraorbital cells were treated using endonasal extended approaches to the frontal sinus and external transpalpebral approach with fat obliteration of the supraorbital cell cavity. Endoscopes were used in all.Results: Four patients had mucoceles located in supraorbital cells. All had erosion of the anterior and inferior wall of the supraorbital cell and entered the orbit, one also had erosion of the posterior wall and the mucocele capsule contacted the meningeal.The disease was resolved in all four patients, but in two of them it was necessary to perform a new combined endonasal and transpalpebral approach, with fat obliteration of the supraorbital cell due to recurrence of the mucocele. Conclusions:The success rate with primary and revision surgery in patients treated by mucoceles located in supraorbital cells was 100%.Mucosal resection, bone drilling, and supraorbital cell obliteration with fat are part of a treatment algorithm, representing the point of greatest surgical aggressiveness.

show abstract

“…These stents have been used to establish long-term ventilation and have been tolerated without difficulty. 10…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Endonasal Management of Recurrent Maxillary Mucoceles Using Biliary T-Tube Stenting

Ono

Homma

et al. 2017

Ear Nose Throat J

View full text Add to dashboard Cite

Mucoceles of the paranasal sinus can be managed endoscopically with an extremely low recurrence rate. Frontal sinus mucoceles can sometimes be prevented from closing and reforming by stenting, which to the best of our knowledge has not yet been reported in the maxillary sinus. We describe the cases of 5 patients—3 men and 2 women, aged 47 to 75 years (mean; 59.6)—with a recurrent and intractable maxillary sinus mucocele that was managed with biliary T-tube stenting. The indications for stenting included recurrent episodes of mucocele with or without a lateral location with a relatively thick bony wall. A latex rubber pediatric biliary T-tube was endoscopically inserted through a window opening into the marsupialized mucocele. The stent was removed 6 to 14 months postoperatively in 4 cases; in the other case, the stent remained adequately positioned for 35 months. None of the patients experienced signs or symptoms of recurrence. We conclude that a T-tube stent can be used successfully to maintain long-term patency in patients with a recurrent and intractable maxillary mucocele, with patency being maintained even after removal of the stent.

show abstract

Endoscopic trans(naso)orbital management of supraorbital mucoceles with biliary T‐tube stenting

Cited by 6 publications

References 31 publications

Development of a Novel T-tube Frontal Sinus Irrigation Catheter

Development of a Novel T-tube Frontal Sinus Irrigation Catheter

Endoscopic Surgery of Supraorbital Cells Mucoceles

Endoscopic Endonasal Management of Recurrent Maxillary Mucoceles Using Biliary T-Tube Stenting

Contact Info

Product

Resources

About